MIRAMAR, Fla., Aug. 04, 2020 (GLOBE NEWSWIRE) -- N
Post# of 36533
(Total Views: 343)
Posted On: 08/25/2020 6:24:21 PM
MIRAMAR, Fla., Aug. 04, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO) today announced that it will hold an investor conference call on Thursday, August 27th at 9:00 am.
During the call, NGIO CEO Joe Moscato will discuss the company’s efforts to develop a vaccine for the COVID-19 pandemic, and the use of the Ii-Key technology as a platform for developing vaccines for other viruses with pandemic potential, including the G4 EA H1 Swine flu that is currently emerging in China. Mr. Moscato will also update shareholders on the company’s plans and timing for listing NGIO on a national exchange.
During the call, NGIO CEO Joe Moscato will discuss the company’s efforts to develop a vaccine for the COVID-19 pandemic, and the use of the Ii-Key technology as a platform for developing vaccines for other viruses with pandemic potential, including the G4 EA H1 Swine flu that is currently emerging in China. Mr. Moscato will also update shareholders on the company’s plans and timing for listing NGIO on a national exchange.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼